Cargando…
Medical resource utilization and costs associated with autosomal dominant polycystic kidney disease in the USA: a retrospective matched cohort analysis of private insurer data
BACKGROUND: Autosomal dominant polycystic kidney disease (ADPKD) results in kidney cyst development and enlargement, resulting in chronic kidney disease (CKD) leading to renal failure. This study sought to determine if ADPKD patients in the early stages of CKD contribute to a sizable economic burden...
Autores principales: | Knight, Tyler, Schaefer, Caroline, Krasa, Holly, Oberdhan, Dorothee, Chapman, Arlene, Perrone, Ronald D |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4345925/ https://www.ncbi.nlm.nih.gov/pubmed/25759590 http://dx.doi.org/10.2147/CEOR.S75523 |
Ejemplares similares
-
Effects of tolvaptan discontinuation in patients with autosomal dominant polycystic kidney disease: a post hoc pooled analysis
por: Lioudis, Michael, et al.
Publicado: (2023) -
Tolvaptan suppresses monocyte chemotactic protein-1 excretion in autosomal-dominant polycystic kidney disease
por: Grantham, Jared J., et al.
Publicado: (2017) -
Polycystic Kidney Disease–Related Disease Burden in Adolescents With Autosomal Dominant Polycystic Kidney Disease: An International Qualitative Study
por: Oberdhan, Dorothee, et al.
Publicado: (2022) -
Caregiver Burden of Autosomal Dominant Polycystic Kidney Disease: A Qualitative Study
por: Oberdhan, Dorothee, et al.
Publicado: (2022) -
The societal economic burden of autosomal dominant polycystic kidney disease in the United States
por: Cloutier, Martin, et al.
Publicado: (2020)